
QNCX
Healthcare · Biotechnology · $32.3M market cap
$39.80+0.02 (+0.1%)Nov 13, 9:30 AM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +86.4% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 11, 2026 | Time not confirmed | -0.83 | — | — |
| Aug 14, 2026 | Before the open | -33.26 | -12.31 | +63.0% |
| Apr 10, 2026 | After the close | -45.00 | -152.00 | -237.8% |
| Mar 3, 2026 | Time not confirmed | -0.18 | -0.41 | -123.3% |
| Nov 12, 2025 | After the close | -44.50 | -50.00 | -12.4% |
| Aug 11, 2025 | After the close | -46.50 | -65.02 | -39.8% |
| May 12, 2025 | Before the open | -0.23 | -0.34 | -47.8% |
| Mar 24, 2025 | After the close | -20.00 | -56.00 | -180.0% |
| Nov 13, 2024 | After the close | -20.00 | -26.00 | -30.0% |
| Aug 13, 2024 | After the close | — | -0.64 | — |
| Apr 1, 2024 | After the close | — | -0.22 | — |
| Feb 14, 2024 | Before the open | -0.28 | -0.22 | +21.4% |
| Nov 14, 2023 | After the close | — | -0.15 |
Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by…
| — |
| Aug 3, 2023 | After the close | 0.00 | -0.14 | — |
| May 15, 2023 | After the close | -0.31 | -0.34 | -10.5% |
| Mar 15, 2023 | After the close | -0.29 | -0.15 | +47.8% |
| Nov 9, 2022 | After the close | -56.72 | -44.00 | +22.4% |
| Aug 9, 2022 | After the close | -56.05 | -102.00 | -82.0% |
| May 10, 2022 | After the close | -111.91 | -144.00 | -28.7% |
| Mar 1, 2022 | After the close | -0.65 | -0.78 | -20.0% |
| Oct 29, 2021 | Before the open | -148.80 | -146.00 | +1.9% |
| Aug 6, 2021 | After the close | -151.65 | -148.00 | +2.4% |
| May 6, 2021 | After the close | -138.54 | -156.00 | -12.6% |
| Mar 1, 2021 | After the close | -0.73 | -0.69 | +5.5% |
| Nov 12, 2020 | After the close | -121.67 | -146.00 | -20.0% |
| Aug 14, 2020 | After the close | -121.63 | -120.00 | +1.3% |
| May 12, 2020 | After the close | -88.93 | -122.00 | -37.2% |
| Mar 16, 2020 | After the close | -0.40 | -0.35 | +12.5% |
| Nov 12, 2019 | After the close | -74.35 | -74.00 | +0.5% |
| Aug 9, 2019 | After the close | -80.00 | -114.00 | -42.5% |
| Jun 12, 2019 | After the close | -0.23 | -1.61 | -600.0% |